Patents by Inventor Carlo Ballatore

Carlo Ballatore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060234909
    Abstract: In one embodiment, provided herein are compositions and methods for increasing drug efficiency. In certain embodiments, the compositions contain conjugates having the formula: D-L-S wherein D is a drug moiety; L, which may or may not be present, is a non-releasing linker moiety; and S is a substrate for a protein or lipid kinase that is overexpressed, overactive or exhibits undesired activity in a target system.
    Type: Application
    Filed: March 14, 2006
    Publication date: October 19, 2006
    Inventors: Michael Newman, Angelo Castellino, Joel Desharnais, Zijian Guo, Qing Li, Carlo Ballatore, Chengzao Sun
  • Publication number: 20060063743
    Abstract: This invention provides compounds and methods for using them to inhibit the growth of microorganism that expresses Peptide Deformylase, the compounds having the general formula:
    Type: Application
    Filed: October 21, 2005
    Publication date: March 23, 2006
    Inventors: Carlo Ballatore, Maria Sergeeva, Venkata Doppalapudi
  • Patent number: 7001922
    Abstract: The invention provides compounds and methods for using them to inhibit the growth of microorganism that expresses Peptide Deformylase, the compounds having the general formula:
    Type: Grant
    Filed: November 14, 2003
    Date of Patent: February 21, 2006
    Assignee: Celmed Oncology (USA), Inc.
    Inventors: Carlo Ballatore, Maria V. Sergeeva, Venkata Ramana Doppalapudi
  • Publication number: 20050187147
    Abstract: In one embodiment, provided herein are compositions and methods for increasing drug efficiency. In certain embodiments, the compositions contain conjugates having the formula: D-L-S wherein D is a drug moiety; L, which may or may not be present, is a non-releasing linker moiety; and S is a substrate for a protein or lipid kinase that is overexpressed, overactive or exhibits undesired activity in a target system.
    Type: Application
    Filed: September 22, 2004
    Publication date: August 25, 2005
    Inventors: Michael Newman, Angelo Castellino, Joel Desharnais, Zijian Guo, Qing Li, Carlo Ballatore, Chengzao Sun
  • Publication number: 20050148534
    Abstract: In certain embodiments, provided herein are compositions and methods for increasing drug efficiency. The conjugates provided are in certain embodiments, for compositions and methods in treatment of variety of diseases and have the formula 1: D-L-S??(1) or formula 2: D-L-S???(2) wherein D is a drug moiety; L, which may or may not be present, is a non-releasing linker moiety; S is a substrate for a kinase, other than a hexokinase, a protein kinase or a lipid kinase; and S? is a substrate for a phosphotransferase, other than a hexokinase, a protein kinase or a lipid kinase.
    Type: Application
    Filed: September 22, 2004
    Publication date: July 7, 2005
    Inventors: Angelo Castellino, Carlo Ballatore, Simon Aspland, Joel Desharnais, Michael Newman, Chengzao Sun, Peter Wirsching
  • Publication number: 20040236096
    Abstract: The invention provides compounds and methods for using them to inhibit the growth of microorganism that expresses Peptide Deformylase, the compounds having the general formula: 1
    Type: Application
    Filed: November 14, 2003
    Publication date: November 25, 2004
    Inventors: Carlo Ballatore, Maria V. Sergeeva, Venkata Ramana Doppalapudi